N-(4-(DIFLUOROMETHOXY)PHENYL)-6-((3R)-3-HYDROXY-1-PYRROLIDINYL)-5-(1H-PYRAZOL-3-YL)-3-PYRIDINECARBOXAMIDE
UNII FW3M6WP2A3
Substance Identification & Data
This profile provides standardized clinical and technical data for N-(4-(difluoromethoxy)phenyl)-6-((3r)-3-hydroxy-1-pyrrolidinyl)-5-(1h-pyrazol-3-yl)-3-pyridinecarboxamide, uniquely identified by the FDA Unique Ingredient Identifier (UNII) FW3M6WP2A3.
Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 3033653-93-6 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.
Detailed Substance Profile
C20H19F2N5O3 BTISNNPYVIGCCJ-CQSZACIVSA-N Synonyms and Nomenclature
This section provides a complete list of nomenclature and identifier mappings for N-(4-(difluoromethoxy)phenyl)-6-((3r)-3-hydroxy-1-pyrrolidinyl)-5-(1h-pyrazol-3-yl)-3-pyridinecarboxamide. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.